PORT OF SPAIN, Trinidad and Tobago — The Caribbean Public Health Agency (CARPHA) and Caribbean Airlines Limited (CAL) have signed a landmark cargo rate agreement that promises to transform how public health specimens move across the region, with direct implications for the speed and reliability of disease surveillance in St. Vincent and the Grenadines and the wider Caribbean.
The International Cargo Rate Agreement, formally signed on 17 April 2026 and announced this week, establishes standardised and preferential rates for shipping public health specimens between CARPHA’s 26 Member States and its three regional referral laboratories in Trinidad, St. Lucia, and Jamaica.
For small island nations like SVG, where rapid laboratory testing often depends on shipping samples abroad, the agreement addresses a long-standing weakness in regional health security: unpredictable costs and logistical delays that can slow outbreak response.
Closing the Distance Between Diagnosis and Action
The deal was signed by CARPHA Executive Director Dr. Lisa Indar and Caribbean Airlines’ Head of Sales, Cargo Division, Mr. Brian Broomes. It tackles two issues that have hampered laboratory referrals for years — cost disparities between Member States and logistical barriers that have, at times, disrupted surveillance activities entirely.
Under the new framework, samples destined for CARPHA’s three referral laboratories will move under a single, predictable rate structure. The CARPHA Medical Microbiology Laboratory (CMML) has also expanded its capabilities, now offering enhanced clinical and antimicrobial resistance (AMR) testing, alongside rapid PCR testing of isolates from clinical, environmental, and animal sources.
In a notable development for cash-strapped national health systems, CARPHA’s Pandemic Fund project will cover the cost of sample transport in the initial phase of the rollout.
Why It Matters for SVG
St. Vincent and the Grenadines, like several OECS Member States, relies heavily on regional referral laboratories for specialised testing — particularly for emerging pathogens, antimicrobial resistance monitoring, and outbreak investigations. When a suspected case of an unusual disease arises in Kingstown, the question of how quickly a specimen can reach Port of Spain or Castries can shape the entire public health response.
Dr. Indar, speaking at the signing, framed the agreement in plain terms: “Strong laboratory referral systems are essential to regional health security. This agreement with Caribbean Airlines supports faster, more reliable movement of specimens for specialised testing, helping our Member States to strengthen surveillance and respond more quickly to public health threats. It is a practical partnership that advances equity in access to advanced diagnostics across the Caribbean and also demonstrates CAL’s commitment to a healthier, safer Caribbean.”
Dr. Gabriel Gonzalez-Escobar, Head of the CMML, was even more direct on the operational stakes. “In public health, time matters,” he said. “When specimens can be shipped more efficiently and at predictable rates, national laboratories are better able to refer samples for specialised testing and maintain continuity of surveillance. This agreement strengthens the laboratory referral network and supports timely detection and response, particularly during outbreaks and for priority pathogens.”
Caribbean Airlines Steps Into a Public Health Role
For Caribbean Airlines, the agreement marks a meaningful expansion of the airline’s regional role beyond passenger and standard cargo services. All shipments under the agreement will be conducted in line with international packaging and safety standards for infectious substances — a non-trivial logistical commitment.
“Caribbean Airlines is proud to partner with CARPHA on this important initiative,” said Mr. Broomes. “By providing a structured, reliable and secure cargo solution, we are supporting the timely transfer of critical samples to CARPHA’s laboratories, which is essential for effective testing and surveillance. This collaboration reflects our commitment to strengthening regional connectivity in a way that supports public health systems and contributes to the safety and well-being of communities across the Caribbean.”
Building Regional Health Security, One Sample at a Time
The COVID-19 pandemic exposed the cost of fragmented public health systems across small island states. CARPHA’s continued investment in its referral laboratory network, paired with affordable and predictable cargo rates from the region’s flag carrier, represents a tangible step toward closing those gaps.
For Vincentian healthcare workers and laboratory professionals, the practical effect should be felt over time: faster turnaround on referred samples, more reliable surveillance data, and better preparedness for the next outbreak — whether dengue, a novel respiratory virus, or an antimicrobial-resistant pathogen.
CARPHA works with its 26 Member States to strengthen laboratory capacity, surveillance, and coordinated response systems across the region. The CMML plays a central role in specialized testing and supports national laboratories through referral services and regional laboratory coordination.